Reed Kelso

Reed Kelso has extensive experience in the biotechnology industry, with a focus on platform integration and laboratory automation. Reed is currently serving as the Vice President of Platform Integration at Eikon Therapeutics, a position they have held since August 2022. Prior to this, Reed held the role of Senior Director of Platform at Eikon Therapeutics from April 2021 to August 2022.

Before joining Eikon Therapeutics, Reed worked at Amazon Lab126 as a Principal Scientist from June 2020 to April 2021. In 2020, they co-founded SummerBio and served as a Co-Founder until June 2020.

From 2019 to 2020, Reed was the Senior Director of Laboratory Automation at Freenome. Reed also worked as a Director at Synthego from 2015 to 2019.

Reed has experience as a Co-Founder and CEO at Alaneo Genetics from 2013 to 2015 and as a Co-Founder at BioNex Solutions from 2009 to 2013. Reed worked as a consultant at Tethys Bioscience, Inc. from 2010 to 2011.

Earlier in their career, Reed served as the Application Systems Manager at Velocity11 from 2005 to 2008. Reed also worked as a Postdoctoral Fellow at the University of California at San Francisco from 2003 to 2006.

Reed Kelso attended New Trier High School, although the specific start and end year are not provided. After high school, they went on to Northwestern University where they earned their Bachelor of Arts (B.A.) degree in Biology from 1990 to 1993. Later, Reed pursued further education and obtained their PhD in Cell Biology from Yale University, spanning from 1997 to 2002.